Curriculum vitae

INFORTIVE

A community of interim CIOs and CTOs. Member since January 2025.

Mandate Assess the GenAI landscape and build a structured offering that guides executive investment decisions.

• Assesses the landscape: analyses GenAI capabilities, vendors and real maturity to establish, with evidence, where the technology creates business value and where it does not.
• Builds the executive offering: turns that analysis into a structured approach for guiding decision-makers: where to invest, where to wait, how to avoid the risks of a moving and unproven technology.
• Anchors it in delivery reality: informed by building systems personally (GenAI generates code but does not yet build durable systems), so the advice holds in practice, not only in slides.

TraceOne · France, UK & India

PLM software for retail and food. €35M revenue; 60+ technical staff (product owners, client teams, developers, QA) across three countries.

Mandate Unblock a next-generation product and resolve the governance crisis around it · ~5 months · handover to a permanent CTO.

• Restored alignment between board and executives and team morale: direct, regular dialogue with the board to defuse a conflict between directors and executive committee members over a PLM roughly four years late, a delay threatening four major clients representing about half of revenue. Re-motivated a team that no longer believed in the product.
• Built and led a taskforce to finish it: an international team (France / UK / India) of thirty engineers, architects and testers plus ten product managers, which put the platform on a credible delivery trajectory for the second half of 2026 where no achievable date had been in sight.
• Delivered a clean handover: diagnosis, validated trajectory and a working delivery team passed to an incoming permanent CTO.

INTRASENSE · Montpellier, France

Medical imaging software. €5M revenue, 60 employees. A fragile single-product company whose radiology line had hit its revenue ceiling.

Mandate Modernise the technology base and lead a diversification through an R&D crisis · ~12 months · R&D moved to Scrum, POC published and certification files in progress on exit.

• Led the diversification through an R&D crisis: it nearly derailed against acute resistance inside the development team. Situation defused and alignment restored around the new direction: R&D restructured around Scrum, hiring and upskilling on the new methodology and on web technologies, and the difficult organisational decisions taken.
• Designed a new product to move up the value chain: with the radiology line at its ceiling, designed a product rooted in Intrasense's core but extending support to oncologists and care teams across the whole cancer pathway, from diagnosis to remission. That shift moved the company from a commoditised viewer to a strategic role in care, with an expected two to threefold revenue expansion. POC published late 2022.
• Moved the platform web-first: delivered as a fully web application, a first for Intrasense, running medical imaging in the browser as a thick client (React, WebAssembly), the browser acting as the radiology console.
• IEC 62304 / 13485 certification files submitted to notified bodies, putting the renewed platform on a compliant route to market.

MAK SYSTEM INTERNATIONAL · Paris, France

Blood and cell therapy management software. €40M revenue, 120 employees. Recalled by the chief executive to lead the next technology cycle.

Mandate Run a tactical bridge on the existing product while defining the next generation · multi-year · exit after the Carlyle majority acquisition.

• Cut database TCO by up to 60%: certified the products on PostgreSQL for blood banks leaving Oracle, behind a database abstraction layer. Opened the smaller blood-bank segment (regional banks in Europe, Latin America and sub-Saharan Africa) and reduced implementation and non-production costs, delivering immediate value while the next generation was built.
• Defined the next-generation platform: a strategy built on lower total cost of ownership, agility, time to market and geographic expansion (Africa, Asia, Latin America), architected cloud-native (containerised micro-services, API-first), upskilling key developers and recruiting cloud profiles.
• Widened the addressable market: a new cell-therapy product added to the catalogue, opening a clinical segment previously unserved.
• Passed investor due diligence: the technical demonstration and review behind Carlyle's acquisition of 70% of MAK SYSTEM in 2020; amount undisclosed.

JOULECO SA · Villepinte, France

Founded to build and market software for sub-Saharan markets. Cloud platform for public-health programme management, built from nothing.

• Built the product and the company from zero: a web platform taken from nothing to production in sub-Saharan Africa, one of the least technically forgiving regions. In service in Senegal (patient records) and the DRC (adverse events).
• Won and delivered a $400K assignment in the DRC: real revenue for a seed-stage startup, in a difficult market.
• Produced a step change in pharmacovigilance: across roughly a tenth of the country's health zones in six months, the platform collected 1,200 adverse-event reports, against roughly 300 nationwide across a full year under the previous manual process, which gave practitioners no incentive to report.

SOFTTHINKS · Villeneuve d'Ascq, France

Backup and recovery software. €10M revenue, 80 employees. A small company long asleep on past success, led through fundamental change.

Mandate Renew the product line and turn around an underperforming R&D organisation · ~21 months · new-segment product shipped and CMMI level 2 in place on exit.

• Opened a new revenue line: a product launched into an entirely new market segment in 14 months, against a usual cycle of roughly 36: revenue the company did not previously have.
• Rebuilt the R&D organisation end to end, from product definition through QA, recruiting new engineers and bringing existing teams up to speed on Agile and new technologies; CMMI level II (SCAMPI B) deployed for measurable process maturity.
• Built and led distributed France and United States teams (Austin, Texas): a Texan team built from scratch and senior developers recruited in France; cross-site collaboration established, inter-team friction resolved, and a near-continuous development cycle achieved across time zones.

MAK SYSTEM INTERNATIONAL · Paris, France

Medical device software. First tenure; recalled as CTO in 2015.

Mandate Replatform the product suite to the web and clear it for the US market · ~3.5 years · FDA 510(k) obtained and the new generation deployed across North America and Europe.

• Opened and won the US market: FDA 510(k) clearance took a product from barred from sale in the United States to market leader: MAK SYSTEM holds 80%+ of the American blood-bank market today and 100% in Canada.
• Modernised the product suite to the web, replatforming a legacy architecture to open the way for the next product generation.
• Deployed a new product generation across North America and Europe, and reshaped the technical teams and client project delivery to sustain it.

• Delivered an optimisation plan for the payments transformation programme (instant and international) at a Moroccan retail and investment bank, covering architecture and development methods.

• Group-wide treasury optimisation: IT roadmap defined for an international cash-pooling initiative at a French universal bank, applicable across all subsidiaries; approved at executive committee in November 2021.

• Delivered a personalisation facility for sovereign documents · authentication of people and goods · for a sub-Saharan African state, in production from early 2013.

• Created and institutionalised a PMO and deployed Scrum for version 1.5 of the internal "Phénix" platform in specialty retail.